In-life Transition of a Global Multi-Study Program

Publish Date:
April 22, 2015

Could Chiltern implement an effective multi-service strategy to keep an in-life hematology/immunology program on target?
With four studies underway and two about to begin, a top global biotech transitioned a poor performing biometrics portfolio to Chiltern. Using the Turbo methodology, the program management team was able to quickly and efficiently implement a rescue strategy with zero interruption.